Zurich / Glattbrugg | February 7, 2019
The first FluidFM User Conference organized by Cytosurge has been a complete success – this was the feedback of our attendees. From Thursday, 31st January, to Friday, 1st February 2019, more than 50 FluidFM users, researchers and partners from around the globe gathered at ETH Hönggerberg in Zurich to showcase their results, gain insights, network and profit from common solutions and approaches.
Many thanks for the great event in Zurich. Justin and I enjoyed it very much. And again, it was really perfectly organized.Martin Winter, Lab Automation Network, Germany
Now, we are looking back to two days full of great exchange, learning, networking and good food. Many thanks to our sponsors who have contributed to this successful event: Olympus as Platinum sponsor, JPK BioAFM Center as Gold sponsor and Nanosurf as Silver sponsor. We would like to thank especially our Platinum sponsor Olympus, who has sponsored the exclusive conference apéro and dinner at the eCHo restaurant in the Marriott hotel. The apéro was not only useful to network and strengthen the FluidFM community, but also to give a small foretaste of the subsequent delicious dinner with typical Swiss dishes. :)
Thank you for kind invitation to the user workshop of Cytosurge. I was very pleased to give a presentation at ETH and meet new friends over there. It is certain to me that Cytosurge will expand and be more successful now.Joon Won Park, POSTECH, Korea
Once again, thank you for the invitation to the very-well organized conference last week, it was great to learn, network and connect!Guillaume Ngo, Novartis Pharma AG, Switzerland
About FluidFM® technology
FluidFM was developed at ETH Zurich and was first commercialized in 2009 by Cytosurge AG, founded as an ETH spin-off. Since a decade, more than 50 scientific papers have mentioned FluidFM technology. FluidFM is cutting edge and unique:
Unimaginably small hollow probes:
Apertures as small as 300 nm enable more than 12 applications such as colloidal studies, single cell adhesion & nano-injection.
Nano-injection of proteins, CRISPR Cas complexes, RNAs and plasmids directly into the nucleus of adherent cells – in a non-destructive and measurable manner.
Combine nano-injection with cell isolation and nano-printing to design totally new research approaches such as building neural networks.
Pinpoint accurate microscopic additive manufacturing:
Print 3D metal objects at the micrometer scale onto existing structures with pinpoint (micrometer) accuracy.
About Cytosurge AG
Claudia Frey, Marketing Manager
Tel. +41 43 544 87 20